Sai Parenterals Limited Issues Compliance Certificate for Q4FY26
Sai Parenterals Limited submitted a compliance certificate for the quarter and year ended March 31, 2026. The company confirmed it has a functional Structured Digital Database (SDD) in place, with proper controls and an 8-year record retention capability. Nine events were captured between January 1, 2026, and March 31, 2026.
This is a routine regulatory compliance report and does not introduce any new material information that would significantly impact the company's operations or stock.
The announcement is a routine compliance filing and does not contain any information that positively or negatively impacts the company's financial performance or future outlook.
Sai Parenterals Limited has issued a compliance certificate for the quarter and year ended March 31, 2026, pertaining to the Structured Digital Database (SDD) as per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
Shivali Aggarwal, Compliance Officer and Company Secretary, certified that the company maintains an internally managed, non-tamperable Structured Digital Database with an audit trail, capable of retaining records for 8 years. The database captures all Unpublished Price Sensitive Information (UPSI) disseminated in the previous quarter and year, along with the nature, date, and time of dissemination. Access controls are in place to manage who can access the SDD.
During the quarter and year ended March 31, 2026, the company captured nine required events from January 1, 2026, to March 31, 2026. The certificate also confirms that no non-compliance was observed in the previous year. The certificate was signed on April 17, 2026, in Hyderabad.
What to do with a filing like this
Sai Parenterals Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sai Parenterals Limited. Read the original for the full detail.